Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients
Introduction: There is no specific anti-viral therapies for 2019 Coronavirus Diseases (COVID-19) infection. Here, we compared patients receiving steroids at different dosages versus no steroids in severe and critical COVID-19 patients. Methods: We retrospectively studied COVID-19 patients who recei...
Main Authors: | Salma AlBahrani, Jaffar A. Al-Tawfiq, Arulanantham Zachariah Jebakumar, Mohammed Alghamdi, Nawaf Zakary, Mariam Seria, Abdulrahman Alrowis |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2021-06-01
|
Series: | Journal of Epidemiology and Global Health |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125957307/view |
Similar Items
-
A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
by: Salma AlBahrani, et al.
Published: (2021-01-01) -
Perioperative “stress dose” of corticosteroid: Pharmacological and clinical perspective
by: Geetanjali T Chilkoti, et al.
Published: (2019-01-01) -
Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study
by: Yichen Li, et al.
Published: (2021-02-01) -
Clinical Profile of Mortality and Treatment Profile of Survival in Patients with COVID-19 Pneumonia Admitted to Dubai Hospital
by: Rashid Nadeem, et al.
Published: (2021-06-01) -
Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
by: Jae Chol Choi, et al.
Published: (2020-10-01)